⌘K

Login Start Free

Home/Filings/144/0000048966-24-000026

144//SEC Filing

Janux Therapeutics, Inc. 144

Accession 0000048966-24-000026

CIK 0001873935other

View on SEC.gov Company Profile

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 9:18 PM ET

Size

5.8 KB

Accession

0000048966-24-000026

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

Avalon BioVentures I, LP

CIK 0001873935

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001873935

Filing Metadata

Form type: 144
Filed: Sep 11, 8:00 PM ET
Accepted: Sep 12, 9:18 PM ET
Size: 5.8 KB

View on SEC.gov